Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and disease

Developmental Dynamics

Volumn 238, Issue 2, 2009, Pages 249-264

  Liao, Siyun ^a   Bodmer, Janet ^a   Pietras, Daniel ^a   Azhar, Mohamad ^b   Doetschman, Tom ^b   Schultz, Jo El J ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Aortic arch; Cardiac fibroblasts; Cardiac hypertrophy; Cardiovascular development; Coronary vessels; Epicardium; Epicardium derived cells; Fibroblast growth factor; Heart valves; Ischemia reperfusion injury; Low and high molecular weight isoforms; Myocardial development; Smooth muscle cells; Transgenic and knockout mouse models; Vascular biology

Indexed keywords

FIBROBLAST GROWTH FACTOR 2;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; GENETIC ANALYSIS; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HUMAN; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW;

ANIMALS; AORTA, THORACIC; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; FIBROBLAST GROWTH FACTOR 2; HEART VALVES; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN ISOFORMS;

EID: 59649128333     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.21677     Document Type: Review

References (163)

1. Abraham JA, Whang JL, Tumolo A, Mergia A, Fiddes JC. 1986. Human basic fibroblast growth factor: nucleotide sequence, genomic organization, and expression in mammalian cells. Cold Spring Harb Symp Quant Biol 51(pt 1):657-668.
2. Aoyama T, Takimoto Y, Pennica D, Inoue R, Shinoda E, Hattori R, Yui Y, Sasayama S. 2000. Augmented expression of cardiotrophin-1 and its receptor component, gp130, in both left and right ventricles after myocardial infarction in the rat. J Mol Cell Cardiol 32:1821-1830.
3. Arese M, Chen Y, Florkiewicz RZ, Gualandris A, Shen B, Rifkin DB. 1999. Nuclear activities of basic fibroblast growth factor: potentiation of low-serum growth mediated by natural or chimeric nuclear localization signals. Mol Biol Cell 10:1429-1444.
4. Arnaud E, Touriol C, Boutonnet C, Gensac MC, Vagner S, Prats H, Prats AC. 1999. A new 34-kilodalton isoform of human fibroblast growth factor 2 is cap dependently synthesized by using a non-AUG start codon and behaves as a survival factor. Mol Cell Biol 19:505-514.
5. Askew DS, Bartholomew C, Ihle JN. 1993. Insertional mutagenesis and the transformation of hematopoietic stem cells. Hematol Pathol 7:1-22.
6. Association AH. 2007. 2007. Heart and stroke statistical update. American Heart Association. Dallas, TX: American Heart Association.
7. Azhar M, Schultz Jel J, Grupp I, Dorn GW Jr, Meneton P, Molin DG, Gittenberger-de Groot AC, Doetschman T. 2003. Transforming growth factor beta in cardiovascular development and function. Cytokine Growth Factor Rev 14:391-407.
8. Baffour R, Berman J, Garb JL, Rhee SW, Kaufman J, Friedmann P. 1992. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg 16:181-191.
9. Bikfalvi A, Klein S, Pintucci G, Rifkin DB. 1997. Biological roles of fibroblast growth factor-2. Endocr Rev 18:26-45.
10. Bouche G, Baldin V, Belenguer P, Prats H, Amalric F. 1994. Activation of rDNA transcription by FGF-2: key role of protein kinase CKII. Cell Mol Biol Res 40:547-554.
11. Bugler B, Amalric F, Prats H. 1991. Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor. Mol Cell Biol 11:573-577.
12. Bush RL, Pevec WC, Ndoye A, Cheung AT, Sasse J, Pearson DN. 1998. Regulation of new blood vessel growth into ischemic skeletal muscle. J Vasc Surg 28:919-928.
13. Butcher JT, Markwald RR. 2007. Valvulogenesis: the moving target. Philos Trans R Soc Lond B Biol Sci 362:1489-1503.
14. Chen B, Bronson RT, Klaman LD, Hampton TG, Wang JF, Green PJ, Magnuson T, Douglas PS, Morgan JP, Neel BG. 2000. Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis. Nat Genet 24:296-299.
15. Cheung WM, Chen SF, Nian GM, Lin TN. 2000. Induction of angiogenesis related genes in the contralateral cortex with a rat three-vessel occlusion model. Chin J Physiol 43:119-124.
16. Choi J, Ko MK, Kay EP. 2000. Subcellular localization of the expressed 18 kDa FGF-2 isoform in corneal endothelial cells. Mol Vis 6:222-231.
17. Choy M, Oltjen SL, Otani YS, Armstrong MT, Armstrong PB. 1996. Fibroblast growth factor-2 stimulates embryonic cardiac mesenchymal cell proliferation. Dev Dyn 206:193-200.
18. Claus P, Doring F, Gringel S, Muller-Ostermeyer F, Fuhlrott J, Kraft T, Grothe C. 2003. Differential intranuclear localization of fibroblast growth factor-2 isoforms and specific interaction with the survival of motoneuron protein. J Biol Chem 278:479-485.
19. Coffin JD, Florkiewicz R, Neumann J, Mort-Hopkins T, Dorn GW Jr, Lightfoot P, German R, Howles PN, Kier A, O'Toole BA, Doetschman T. 1995. Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. Mol Biol Cell 6:1861-1873.
20. Consigli SA, Joseph-Silverstein J. 1991. Immunolocalization of basic fibroblast growth factor during chicken cardiac development. J Cell Physiol 146:379-385.
21. Cooper DN, Barondes SH. 1990. Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism. J Cell Biol 110:1681-1691.
22. Cuevas P, Barrios V, Gimenez-Gallego G, Martinez-Coso V, Cuevas B, Benavides J, Garcia-Segovia J, Asin-Cardiel E. 1997a. Serum levels of basic fibroblast growth factor in acute myocardial infarction. Eur J Med Res 2:282-284.
23. Cuevas P, Reimers D, Carceller F, Martinez-Coso V, Redondo-Horcajo M, Saenz de Tejada I, Gimenez-Gallego G. 1997b. Fibroblast growth factor-1 prevents myocardial apoptosis triggered by ischemia reperfusion injury. Eur J Med Res 2:465-468.
24. Cuevas P, Carceller F, Martinez-Coso V, Asin-Cardiel E, Gimenez-Gallego G. 2000. Fibroblast growth factor cardioprotection against ischemia-reperfusion injury may involve K+ ATP channels. Eur J Med Res 5:145-149.
25. Davis MG, Zhou M, Ali S, Coffin JD, Doetschman T, Dorn GW Jr. 1997. Intracrine and autocrine effects of basic fibroblast growth factor in vascular smooth muscle cells. J Mol Cell Cardiol 29:1061-1072.
26. Delrieu I, Arnaud E, Ferjoux G, Bayard F, Faye JC. 1998. Overexpression of the FGF-2 24-kDa isoform up-regulates IL-6 transcription in NIH-3T3 cells. FEBS Lett 436:17-22.
27. Dhalla NS, Elmoselhi AB, Hata T, Makino N. 2000. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res 47:446-456.
28. Doble BW, Fandrich RR, Liu L, Padua RR, Kardami E. 1990. Calcium protects pituitary basic fibroblast growth factors from limited proteolysis by co-purifying proteases. Biochem Biophys Res Commun 173:1116-1122.
29. Doble BW, Chen Y, Bosc DG, Litchfield DW, Kardami E. 1996. Fibroblast growth factor-2 decreases metabolic coupling and stimulates phosphorylation as well as masking of connexin43 epitopes in cardiac myocytes. Circ Res 79:647-658.
30. Doble BW, Dang X, Ping P, Fandrich RR, Nickel BE, Jin Y, Cattini PA, Kardami E. 2004. Phosphorylation of serine 262 in the gap junction protein connexin-43 regulates DNA synthesis in cell-cell contact forming cardiomyocytes. J Cell Sci 117:507-514.
31. Dono R, Zeller R. 1994. Cell-type-specific nuclear translocation of fibroblast growth factor-2 isoforms during chicken kidney and limb morphogenesis. Dev Biol 163:316-330.
32. Dono R, James D, Zeller R. 1998a. A GR-motif functions in nuclear accumulation of the large FGF-2 isoforms and interferes with mitogenic signalling. Oncogene 16:2151-2158.
33. Dono R, Texido G, Dussel R, Ehmke H, Zeller R. 1998b. Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice. EMBO J 17:4213-4225.
34. Eriksson AE, Cousens LS, Weaver LH, Matthews BW. 1991. Three-dimensional structure of human basic fibroblast growth factor. Proc Natl Acad Sci U S A 88:3441-3445.
35. Feige JJ, Baird A. 1989. Basic fibroblast growth factor is a substrate for protein phosphorylation and is phosphorylated by capillary endothelial cells in culture. Proc Natl Acad Sci U S A 86:3174-3178.
36. Florkiewicz RZ, Anchin J, Baird A. 1998. The inhibition of fibroblast growth factor-2 export by cardenolides implies a novel function for the catalytic subunit of Na+,K+-ATPase. J Biol Chem 273:544-551.
37. Foletti A, Vuadens F, Beermann F. 2003. Nuclear localization of mouse fibroblast growth factor 2 requires N-terminal and C-terminal sequences. Cell Mol Life Sci 60:2254-2265.
38. Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodavsky I. 1988. A heparin-binding angiogenic protein - basic fibroblast growth factor - is stored within basement membrane. Am J Pathol 130:393-400.
39. Fontaine V, Filipe C, Werner N, Gourdy P, Billon A, Garmy-Susini B, Brouchet L, Bayard F, Prats H, Doetschman T, Nickenig G, Arnal JF. 2006. Essential role of bone marrow fibroblast growth factor-2 in the effect of estradiol on re-endothelialization and endothelial progenitor cell mobilization. Am J Pathol 169:1855-1862.
40. Fontijn D, Duyndam MC, Belien JA, Gallegoz Ruiz MI, Pinedo HM, Boven E. 2007. The 18 kDa isoform of basic fibroblast growth factor is sufficient to stimulate human melanoma growth and angiogenesis. Melanoma Res 17:155-168.
41. Franciosi JP, Bolender DL, Lough J, Kolesari GL. 2000. FGF-2-induced imbalance in early embryonic heart cell proliferation: a potential cause of late cardiovascular anomalies. Teratology 62:189-194.
42. Freed DH, Moon MC, Borowiec AM, Jones SC, Zahradka P, Dixon IM. 2003. Cardiotrophin-1: expression in experimental myocardial infarction and potential role in post-MI wound healing. Mol Cell Biochem 254:247-256.
43. Frelin C, Ladoux A, D'Angelo G. 2000. Vascular endothelial growth factors and angiogenesis. Ann Endocrinol (Paris) 61:70-74.
44. Friesel RE, Maciag T. 1995. Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J 9:919-925.
45. Fu XB, Yang YH, Sun TZ, Chen W, Li JY, Sheng ZY. 2003. Rapid mitogen-activated protein kinase by basic fibroblast growth factor in rat intestine after ischemia/reperfusion injury. World J Gastroenterol 9:1312-1317.
46. Fujita M, Ikemoto M, Kishishita M, Otani H, Nohara R, Tanaka T, Tamaki S, Yamazato A, Sasayama S. 1996. Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina. Circulation 94:610-613.
47. Gajdusek CM, Carbon S. 1989. Injury-induced release of basic fibroblast growth factor from bovine aortic endothelium. J Cell Physiol 139:570-579.
48. Garcia-Dorado D, Rodriguez-Sinovas A, Ruiz-Meana M, Inserte J, Agullo L, Cabestrero A. 2006. The end-effectors of preconditioning protection against myocardial cell death secondary to ischemia-reperfusion. Cardiovasc Res 70:274-285.
49. Garmy-Susini B, Delmas E, Gourdy P, Zhou M, Bossard C, Bugler B, Bayard F, Krust A, Prats AC, Doetschman T, Prats H, Arnal JF. 2004. Role of fibroblast growth factor-2 isoforms in the effect of estradiol on endothelial cell migration and proliferation. Circ Res 94:1301-1309.
50. Gross GJ, Auchampach JA. 2007. Reperfusion injury: does it exist? J Mol Cell Cardiol 42:12-18.
51. Hasdai D, Barak V, Leibovitz E, Herz I, Sclarovsky S, Eldar M, Scheinowitz M. 1997. Serum basic fibroblast growth factor levels in patients with ischemic heart disease. Int J Cardiol 59:133-138.
52. Hausenloy DJ, Yellon DM. 2006. Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res 70:240-253.
53. He ZY, Feng B, Yang SL, Luo HL. 2005. Intracardiac basic fibroblast growth factor and transforming growth factor-beta 1 mRNA and their proteins expression level in patients with pressure or volume-overload right or left ventricular hypertrophy. Acta Cardiol 60:21-25.
54. Hellman U, Hellstrom M, Morner S, Engstrom-Laurent A, Aberg AM, Oliviero P, Samuel JL, Waldenstrom A. 2008. Parallel up-regulation of FGF-2 and hyaluronan during development of cardiac hypertrophy in rat. Cell Tissue Res 332:49-56.
55. Horrigan MC, Malycky JL, Ellis SG, Topol EJ, Nicolini FA. 1999. Reduction in myocardial infarct size by basic fibroblast growth factor following coronary occlusion in a canine model. Int J Cardiol 68(suppl 1):S85-S91.
56. House SL. 2005. Role of fibroblast growth factor 2 in cardiac ischemia-reperfusion injury and cardiac hypertrophy. In: Pharmacology and cell biophysics. Cincinnati: University of Cincinnati.
57. House SL, Bolte C, Zhou M, Doetschman T, Klevitsky R, Newman G, Schultz Jel J. 2003. Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia. Circulation 108:3140-3148.
58. House SL, Branch K, Newman G, Doetschman T, Schultz Jel J. 2005. Cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2 is mediated by the MAPK cascade. Am J Physiol Heart Circ Physiol 289:H2167-H2175.
59. House SL, Melhorn SJ, Newman G, Doetschman T, Schultz Jel J. 2007. The protein kinase C pathway mediates cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2. Am J Physiol Heart Circ Physiol 293:H354-H365.
60. Hughes SE. 1997. Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues. J Histochem Cytochem 45:1005-1019.
61. Itoh N, Ornitz DM. 2004. Evolution of the Fgf and Fgfr gene families. Trends Genet 20:563-569.
62. Itoh N, Ornitz DM. 2008. Functional evolutionary history of the mouse Fgf gene family. Dev Dyn 237:18-27.
63. Jaye M, Howk R, Burgess W, Ricca GA, Chiu IM, Ravera MW, O'Brien SJ, Modi WS, Maciag T, Drohan WN. 1986. Human endothelial cell growth factor: cloning, nucleotide sequence, and chromosome localization. Science 233:541-545.
64. Jiang N, Finklestein SP, Do T, Caday CG, Charette M, Chopp M. 1996. Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces infarct volume in a model of focal cerebral ischemia/reperfusion in the rat. J Neurol Sci 139:173-179.
65. Jiang ZS, Padua RR, Ju H, Doble BW, Jin Y, Hao J, Cattini PA, Dixon IM, Kardami E. 2002. Acute protection of ischemic heart by FGF-2: involvement of FGF-2 receptors and protein kinase C. Am J Physiol Heart Circ Physiol 282:H1071-H1080.
66. Jiang ZS, Srisakuldee W, Soulet F, Bouche G, Kardami E. 2004. Non-angiogenic FGF-2 protects the ischemic heart from injury, in the presence or absence of reperfusion. Cardiovasc Res 62:154-166.
67. Jiang ZS, Jeyaraman M, Wen GB, Fandrich RR, Dixon IM, Cattini PA, Kardami E. 2007. High- but not low-molecular weight FGF-2 causes cardiac hypertrophy in vivo; possible involvement of cardiotrophin-1. J Mol Cell Cardiol 42:222-233.
68. Kardami E, Fandrich RR. 1989. Basic fibroblast growth factor in atria and ventricles of the vertebrate heart. J Cell Biol 109:1865-1875.
69. Kardami E, Liu L, Doble BW. 1991a. Basic fibroblast growth factor in cultured cardiac myocytes. Ann N Y Acad Sci 638:244-255.
70. Kardami E, Stoski RM, Doble BW, Yamamoto T, Hertzberg EL, Nagy JI. 1991b. Biochemical and ultrastructural evidence for the association of basic fibroblast growth factor with cardiac gap junctions. J Biol Chem 266:19551-19557.
71. Kardami E, Jiang ZS, Jimenez SK, Hirst CJ, Sheikh F, Zahradka P, Cattini PA. 2004. Fibroblast growth factor 2 isoforms and cardiac hypertrophy. Cardiovasc Res 63:458-466.
72. Kardami E, Detillieux K, Ma X, Jiang Z, Santiago JJ, Jimenez SK, Cattini PA. 2007. Fibroblast growth factor-2 and cardioprotection. Heart Fail Rev 12:267-277.
73. Kaye D, Pimental D, Prasad S, Maki T, Berger HJ, McNeil PL, Smith TW, Kelly RA. 1996. Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro. J Clin Invest 97:281-291.
74. Kessler DA, Langer RS, Pless NA, Folkman J. 1976. Mast cells and tumor angiogenesis. Int J Cancer 18:703-709.
75. Kim-Schulze S, Lowe WL Jr, Schnaper HW. 1998. Estrogen stimulates delayed mitogen-activated protein kinase activity in human endothelial cells via an autocrine loop that involves basic fibroblast growth factor. Circulation 98:413-421.
76. Kruithof BP, van Wijk B, Somi S, Kruithof-de Julio M, Perez Pomares JM, Weesie F, Wessels A, Moorman AF, van den Hoff MJ. 2006. BMP and FGF regulate the differentiation of multipotential pericardial mesoderm into the myocardial or epicardial lineage. Dev Biol 295:507-522.
77. Laham RJ, Sellke FW, Edelman ER, Pearlman JD, Ware JA, Brown DL, Gold JP, Simons M. 1999. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 100:1865-1871.
78. Laham RJ, Post M, Sellke FW, Simons M. 2000. Therapeutic Angiogenesis Using Local Perivascular and Pericardial Delivery. Curr Interv Cardiol Rep 2:213-217.
79. Landriscina M, Soldi R, Bagala C, Micucci I, Bellum S, Tarantini F, Prudovsky I, Maciag T. 2001. S100A13 participates in the release of fibroblast growth factor 1 in response to heat shock in vitro. J Biol Chem 276:22544-22552.
80. Lavine KJ, Ornitz DM. 2008. Fibroblast growth factors and Hedgehogs: at the heart of the epicardial signaling center. Trends Genet 24:33-40.
81. Lavine KJ, Yu K, White AC, Zhang X, Smith C, Partanen J, Ornitz DM. 2005. Endocardial and epicardial derived FGF signals regulate myocardial proliferation and differentiation in vivo. Dev Cell 8:85-95.
82. Levin EG, Sikora L, Ding L, Rao SP, Sriramarao P. 2004. Suppression of tumor growth and angiogenesis in vivo by a truncated form of 24-kd fibroblast growth factor (FGF)-2. Am J Pathol 164:1183-1190.
83. Liao S, Newman G, Doetschman T, Schultz Jel J. 2007a. Role of high molecular weight isoforms of fibroblast growth factor-2 (FGF-2) in cardiac ischemia-reperfusion injury (I/R) (abstract). J Mol Cell Cardiol 42:S187.
84. Liao S, Porter D, Scott A, Newman G, Doetschman T, Schultz Jel J. 2007b. The cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: the role of JNK signaling. J Mol Cell Cardiol 42:106-120.
85. Lie-Venema H, van den Akker NM, Bax NA, Winter EM, Maas S, Kekarainen T, Hoeben RC, deRuiter MC, Poelmann RE, Gittenberger-de Groot AC. 2007. Origin, fate, and function of epicardium-derived cells (EPDCs) in normal and abnormal cardiac development. ScientificWorldJournal 7:1777-1798.
86. Ma X, Dang X, Claus P, Hirst C, Fandrich RR, Jin Y, Grothe C, Kirshenbaum LA, Cattini PA, Kardami E. 2007. Chromatin compaction and cell death by high molecular weight FGF-2 depend on its nuclear localization, intracrine ERK activation, and engagement of mitochondria. J Cell Physiol 213:690-698.
87. McNeil PL, Ito S. 1989. Gastrointestinal cell plasma membrane wounding and resealing in vivo. Gastroenterology 96:1238-1248.
88. Mellman I, Warren G. 2000. The road taken: past and future foundations of membrane traffic. Cell 100:99-112.
89. Merki E, Zamora M, Raya A, Kawakami Y, Wang J, Zhang X, Burch J, Kubalak SW, Kaliman P, Belmonte JC, Chien KR, Ruiz-Lozano P. 2005. Epicardial retinoid X receptor alpha is required for myocardial growth and coronary artery formation. Proc Natl Acad Sci U S A 102:18455-18460.
90. Mignatti P, Morimoto T, Rifkin DB. 1992. Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J Cell Physiol 151:81-93.
91. Molin D, Post MJ. 2007. Therapeutic angiogenesis in the heart: protect and serve. Curr Opin Pharmacol 7:158-163.
92. Molkentin JD, Dorn IG Jr. 2001. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 63:391-426.
93. Montero A, Okada Y, Tomita M, Ito M, Tsurukami H, Nakamura T, Doetschman T, Coffin JD, Hurley MM. 2000. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest 105:1085-1093.
94. Montesano R, Vassalli JD, Baird A, Guillemin R, Orci L. 1986. Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci U S A 83:7297-7301.
95. Morabito CJ, Dettman RW, Kattan J, Collier JM, Bristow J. 2001. Positive and negative regulation of epicardial-mesenchymal transformation during avian heart development. Dev Biol 234:204-215.
96. Moy FJ, Seddon AP, Bohlen P, Powers R. 1996. High-resolution solution structure of basic fibroblast growth factor determined by multidimensional heteronuclear magnetic resonance spectroscopy. Biochemistry 35:13552-13561.
97. Mukdsi JH, De Paul AL, Petiti JP, Gutierrez S, Aoki A, Torres AI. 2006. Pattern of FGF-2 isoform expression correlated with its biological action in experimental prolactinomas. Acta Neuropathol 112:491-501.
98. Narine K, De Wever O, Van Valckenborgh D, Francois K, Bracke M, DeSmet S, Mareel M, Van Nooten G. 2006. Growth factor modulation of fibroblast proliferation, differentiation, and invasion: implications for tissue valve engineering. Tissue Eng 12:2707-2716.
99. Nishijima K, Ng YS, Zhong L, Bradley J, Schubert W, Jo N, Akita J, Samuelsson SJ, Robinson GS, Adamis AP, Shima DT. 2007. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol 171:53-67.
100. Olivey HE, Compton LA, Barnett JV. 2004. Coronary vessel development: the epicardium delivers. Trends Cardiovasc Med 14:247-251.
101. Ornitz DM, Itoh N. 2001. Fibroblast growth factors. Genome Biol 2:REVIEWS3005.
102. Ortega S, Ittmann M, Tsang SH, Ehrlich M, Basilico C. 1998. Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc Natl Acad Sci U S A 95:5672-5677.
103. Padua RR, Kardami E. 1993. Increased basic fibroblast growth factor (bFGF) accumulation and distinct patterns of localization in isoproterenol-induced cardiomyocyte injury. Growth Factors 8:291-306.
104. Padua RR, Sethi R, Dhalla NS, Kardami E. 1995. Basic fibroblast growth factor is cardioprotective in ischemia-reperfusion injury. Mol Cell Biochem 143:129-135.
105. Padua RR, Merle PL, Doble BW, Yu CH, Zahradka P, Pierce GN, Panagia V, Kardami E. 1998. FGF-2-induced negative inotropism and cardioprotection are inhibited by chelerythrine: involvement of sarcolemmal calcium-independent protein kinase C. J Mol Cell Cardiol 30:2695-2709.
106. Parker TG, Packer SE, Schneider MD. 1990. Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes. J Clin Invest 85:507-514.
107. Pasumarthi KB, Kardami E, Cattini PA. 1996. High and low molecular weight fibroblast growth factor-2 increase proliferation of neonatal rat cardiac myocytes but have differential effects on binucleation and nuclear morphology. Evidence for both paracrine and intracrine actions of fibroblast growth factor-2. Circ Res 78:126-136.
108. Pellieux C, Foletti A, Peduto G, Aubert JF, Nussberger J, Beermann F, Brunner HR, Pedrazzini T. 2001. Dilated cardiomyopathy and impaired cardiac hypertrophic response to angiotensin II in mice lacking FGF-2. J Clin Invest 108:1843-1851.
109. Pennisi DJ, Ballard VL, Mikawa T. 2003. Epicardium is required for the full rate of myocyte proliferation and levels of expression of myocyte mitogenic factors FGF2 and its receptor, FGFR-1, but not for transmural myocardial patterning in the embryonic chick heart. Dev Dyn 228:161-172.
110. Person AD, Klewer SE, Runyan RB. 2005. Cell biology of cardiac cushion development. Int Rev Cytol 243:287-335.
111. Peters NS, Wit AL. 2000. Gap junction remodeling in infarction: does it play a role in arrhythmogenesis? J Cardiovasc Electrophysiol 11:488-490.
112. Pintucci G, Yu PJ, Saponara F, Kadian-Dodov DL, Galloway AC, Mignatti P. 2005. PDGF-BB induces vascular smooth muscle cell expression of high molecular weight FGF-2, which accumulates in the nucleus. J Cell Biochem 95:1292-1300.
113. Piotrowicz RS, Ding L, Maher P, Levin EG. 2001. Inhibition of cell migration by 24-kDa fibroblast growth factor-2 is dependent upon the estrogen receptor. J Biol Chem 276:3963-3970.
114. Plouet J, Mascarelli F, Loret MD, Faure JP, Courtois Y. 1988. Regulation of eye derived growth factor binding to membranes by light, ATP or GTP in photoreceptor outer segments. EMBO J 7:373-376.
115. Post MJ, Laham R, Sellke FW, Simons M. 2001. Therapeutic angiogenesis in cardiology using protein formulations. Cardiovasc Res 49:522-531.
116. Powell PP, Klagsbrun M. 1991. Three forms of rat basic fibroblast growth factor are made from a single mRNA and localize to the nucleus. J Cell Physiol 148:202-210.
117. Presta M, Rusnati M, Urbinati C, Sommer A, Ragnotti G. 1991. Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. J Cell Physiol 149:512-524.
118. Prudovsky I, Bagala C, Tarantini F, Mandinova A, Soldi R, Bellum S, Maciag T. 2002. The intracellular translocation of the components of the fibroblast growth factor 1 release complex precedes their assembly prior to export. J Cell Biol 158:201-208.
119. Prudovsky I, Mandinova A, Soldi R, Bagala C, Graziani I, Landriscina M, Tarantini F, Duarte M, Bellum S, Doherty H, Maciag T. 2003. The non-classical export routes: FGF1 and IL-1alpha point the way. J Cell Sci 116:4871-4881.
120. Quarto N, Finger FP, Rifkin DB. 1991. The NH2-terminal extension of high molecular weight bFGF is a nuclear targeting signal. J Cell Physiol 147:311-318.
121. Quarto N, Fong KD, Longaker MT. 2005. Gene profiling of cells expressing different FGF-2 forms. Gene 356:49-68.
122. Rajanayagam MA, Shou M, Thirumurti V, Lazarous DF, Quyyumi AA, Goncalves L, Stiber J, Epstein SE, Unger EF. 2000. Intracoronary basic fibroblast growth factor enhances myocardial collateral perfusion in dogs. J Am Coll Cardiol 35:519-526.
123. Renko M, Quarto N, Morimoto T, Rifkin DB. 1990. Nuclear and cytoplasmic localization of different basic fibroblast growth factor species. J Cell Physiol 144:108-114.
124. Rothman JE, Wieland FT. 1996. Protein sorting by transport vesicles. Science 272:227-234.
125. Schafer T, Zentgraf H, Zehe C, Brugger B, Bernhagen J, Nickel W. 2004. Unconventional secretion of fibroblast growth factor 2 is mediated by direct translocation across the plasma membrane of mammalian cells. J Biol Chem 279:6244-6251.
126. Schultz JE, Witt SA, Nieman ML, Reiser PJ, Engle SJ, Zhou M, Pawlowski SA, Lorenz JN, Kimball TR, Doetschman T. 1999. Fibroblast growth factor-2 mediates pressure-induced hypertrophic response. J Clin Invest 104:709-719.
127. Schultz Jel J, Witt SA, Glascock BJ, Nieman ML, Reiser PJ, Nix SL, Kimball TR, Doetschman T. 2002. TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. J Clin Invest 109:787-796.
128. Sellke FW, Laham RJ, Edelman ER, Pearlman JD, Simons M. 1998. Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results. Ann Thorac Surg 65:1540-1544.
129. Sessa C, Vigano L, Grasselli G, Trigo J, Marimon I, Llado A, Locatelli A, Ielmini N, Marsoni S, Gianni L. 2006. Phase I clinical and pharmacological evaluation of the multi-tyrosine kinase inhibitor SU006668 by chronic oral dosing. Eur J Cancer 42:171-178.
130. Sheikh F, Sontag DP, Fandrich RR, Kardami E, Cattini PA. 2001. Overexpression of FGF-2 increases cardiac myocyte viability after injury in isolated mouse hearts. Am J Physiol Heart Circ Physiol 280:H1039-H1050.
131. Sheng Z, Lewis JA, Chirico WJ. 2004. Nuclear and nucleolar localization of 18-kDa fibroblast growth factor-2 is controlled by C-terminal signals. J Biol Chem 279:40153-40160.
132. Simons M, Annex BH, Laham RJ, Kleiman N, Henry T, Dauerman H, Udelson JE, Gervino EV, Pike M, Whitehouse MJ, Moon T, Chronos NA. 2002. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 105:788-793.
133. Smith JH, Green CR, Peters NS, Rothery S, Severs NJ. 1991. Altered patterns of gap junction distribution in ischemic heart disease. An immunohistochemical study of human myocardium using laser scanning confocal microscopy. Am J Pathol 139:801-821.
134. Sommer A, Brewer MT, Thompson RC, Moscatelli D, Presta M, Rifkin DB. 1987. A form of human basic fibroblast growth factor with an extended amino terminus. Biochem Biophys Res Commun 144:543-550.
135. Sorensen V, Nilsen T, Wiedlocha A. 2006. Functional diversity of FGF-2 isoforms by intracellular sorting. Bioessays 28:504-514.
136. Speir E, Tanner V, Gonzalez AM, Farris J, Baird A, Casscells W. 1992. Acidic and basic fibroblast growth factors in adult rat heart myocytes. Localization, regulation in culture, and effects on DNA synthesis. Circ Res 71:251-259.
137. Spirito P, Fu YM, Yu ZX, Epstein SE, Casscells W. 1991. Immunohistochemical localization of basic and acidic fibroblast growth factors in the developing rat heart. Circulation 84:322-332.
138. Spruill LS, Baicu CF, Zile MR, McDermott PJ. 2008. Selective translation of mRNAs in the left ventricular myocardium of the mouse in response to acute pressure overload. J Mol Cell Cardiol 44:69-75.
139. Srisakuldee W, Nickel BE, Fandrich RR, Jiang ZS, Kardami E. 2006. Administration of FGF-2 to the heart stimulates connexin-43 phosphorylation at protein kinase C target sites. Cell Commun Adhes 13:13-19.
140. Sugi Y, Sasse J, Barron M, Lough J. 1995. Developmental expression of fibroblast growth factor receptor-1 (cek-1; flg) during heart development. Dev Dyn 202:115-125.
141. Sun G, Doble BW, Sun JM, Fandrich RR, Florkiewicz R, Kirshenbaum L, Davie JR, Cattini PA, Kardami E. 2001. CUG-initiated FGF-2 induces chromatin compaction in cultured cardiac myocytes and in vitro. J Cell Physiol 186:457-467.
142. Syed IS, Sanborn TA, Rosengart TK. 2004. Therapeutic angiogenesis: a biologic bypass. Cardiology 101:131-143.
143. Taverna S, Ghersi G, Ginestra A, Rigogliuso S, Pecorella S, Alaimo G, Saladino F, Dolo V, Dell'Era P, Pavan A, Pizzolanti G, Mignatti P, Presta M, Vittorelli ML. 2003. Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. J Biol Chem 278:51911-51919.
144. Thompson SA. 1992. The disulfide structure of bovine pituitary basic fibroblast growth factor. J Biol Chem 267:2269-2273.
145. Thompson RW, Whalen GF, Saunders KB, Hores T, D'Amore PA. 1990. Heparin-mediated release of fibroblast growth factor-like activity into the circulation of rabbits. Growth Factors 3:221-229.
146. Udelson JE, Dilsizian V, Laham RJ, Chronos N, Vansant J, Blais M, Galt JR, Pike M, Yoshizawa C, Simons M. 2000. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease. Circulation 102:1605-1610.
147. Uhlen P, Burch PM, Zito CI, Estrada M, Ehrlich BE, Bennett AM. 2006. Gain-of-function/Noonan syndrome SHP-2/Ptpn11 mutants enhance calcium oscillations and impair NFAT signaling. Proc Natl Acad Sci U S A 103:2160-2165.
148. Unger EF, Banai S, Shou M, Lazarous DF, Jaklitsch MT, Scheinowitz M, Correa R, Klingbeil C, Epstein SE. 1994. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol 266:H1588-H1595.
149. Unger EF, Goncalves L, Epstein SE, Chew EY, Trapnell CB, Cannon RO III, Quyyumi AA. 2000. Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris. Am J Cardiol 85:1414-1419.
150. Vaccarino FM, Schwartz ML, Raballo R, Nilsen J, Rhee J, Zhou M, Doetschman T, Coffin JD, Wyland JJ, Hung YT. 1999. Changes in cerebral cortex size are governed by fibroblast growth factor during embryogenesis. Nat Neurosci 2:848.
151. Villanueva S, Cespedes C, Gonzalez A, Vio CP. 2006. bFGF induces an earlier expression of nephrogenic proteins after ischemic acute renal failure. Am J Physiol Regul Integr Comp Physiol 291:R1677-R1687.
152. Walgenbach KJ, Gratas C, Shestak KC, Becker D. 1995. Ischaemia-induced expression of bFGF in normal skeletal muscle: a potential paracrine mechanism for mediating angiogenesis in ischaemic skeletal muscle. Nat Med 1:453-459.
153. Walter P, Gilmore R, Blobel G. 1984. Protein translocation across the endoplasmic reticulum. Cell 38:5-8.
154. Wang JM, Hayashi T, Zhang WR, Sakai K, Shiro Y, Abe K. 2000. Reduction of ischemic brain injury by topical application of insulin-like growth factor-I after transient middle cerebral artery occlusion in rats. Brain Res 859:381-385.
155. Witte L, Fuks Z, Haimovitz-Friedman A, Vlodavsky I, Goodman DS, Eldor A. 1989. Effects of irradiation on the release of growth factors from cultured bovine, porcine, and human endothelial cells. Cancer Res 49:5066-5072.
156. Yanagisawa-Miwa A, Uchida Y, Nakamura F, Tomaru T, Kido H, Kamijo T, Sugimoto T, Kaji K, Utsuyama M, Kurashima C, et al. 1992. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 257:1401-1403.
157. Yu PJ, Ferrari G, Pirelli L, Galloway AC, Mignatti P, Pintucci G. 2008. Thrombin cleaves the high molecular weight forms of basic fibroblast growth factor (FGF-2): a novel mechanism for the control of FGF-2 and thrombin activity. Oncogene 27:2594-2601.
158. Zehe C, Engling A, Wegehingel S, Schafer T, Nickel W. 2006. Cell-surface heparan sulfate proteoglycans are essential components of the unconventional export machinery of FGF-2. Proc Natl Acad Sci U S A 103:15479-15484.
159. Zhang M, Ma YF, Gan JX, Jiang GY, Xu SX, Tao XL, Hong A, Li JK. 2005. Basic fibroblast growth factor alleviates brain injury following global ischemia reperfusion in rabbits. J Zhejiang Univ Sci B 6:637-643.
160. Zhao Z, Rivkees SA. 2000. Programmed cell death in the developing heart: regulation by BMP4 and FGF2. Dev Dyn 217:388-400.
161. Zhou M. 1997. Role of fibroblast growth factor 2 in cardiovascular development and function. In: Molecular genetics. Cincinnati: University of Cincinnati.
162. Zhou M, Sutliff RL, Paul RJ, Lorenz JN, Hoying JB, Haudenschild CC, Yin M, Coffin JD, Kong L, Kranias EG, Luo W, Boivin GP, Duffy JJ, Pawlowski SA, Doetschman T. 1998. Fibroblast growth factor 2 control of vascular tone. Nat Med 4:201-207.
163. Zhu X, Komiya H, Chirino A, Faham S, Fox GM, Arakawa T, Hsu BT, Rees DC. 1991. Three-dimensional structures of acidic and basic fibroblast growth factors. Science 251:90-93.